Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Admission Toxigenic C. Difficile Surveillance to Reduce Hospital Onset C. Difficile Infection (CDI)

NCT04014608 is registered in ClinicalTrials.gov with Endeavor Health as lead sponsor.

NCT NCT04014608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04014608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Admission Toxigenic C. Difficile Surveillance to Reduce Hospital Onset C. Difficile Infection (CDI)
Lead sponsor
Endeavor Health
Phase
Observational
Overall status
Completed
Start date
July 1, 2016
Completion date
December 31, 2018
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile infection